Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment
Key facts
- Who runs it
- Montefiore Medical Center
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 200 people, planned
- Started
- Oct 2026
- Expected to end
- Oct 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Metoclopramide 10mg
- Acetaminophen
- Record updated
- 1 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Adults presenting to one of the study emergency departments (EDs)
- Acute minor traumatic brain injury/concussion as defined by the Zurich Consensus Statement, including symptoms in somatic, cognitive, emotional, behavioral, physical, cognitive impairment, or sleep domains
- ED visit occurring within 7 days of the head injury
- Overall pain intensity greater than >=6 on a 0-10 scale
- Rivermead Post-Concussion Questionnaire (RPQ) score of at least 10
- Reported post-concussion symptoms were not present prior to the injury
- Treating attending physician plans to administer a parenteral medication
Who cannot take part
- Already treated with an anti-dopaminergic medication for post-concussion symptoms
- Contraindications to study medications, including:
- Use of monoamine oxidase (MAO) inhibitors
- Use of anti-rejection transplant medications
- Seizure disorder
- Parkinson's disease
- Pheochromocytoma
- Pregnant patients will not be excluded because both acetaminophen and metoclopramide are commonly used during pregnancy
Where in United States
- Montefiore Medical CenterNew York, United StatesContact: Hamed Sarikhani Assistant Professor of Emergency Medicine, MDNot yet recruiting
About the trial
What the trial wants to find out
The IMPACT study is a randomized, double-blind clinical trial evaluating two commonly used intravenous medications - metoclopramide and acetaminophen - for treating acute post-concussion symptoms in emergency department patients after mild head injury. The study aims to determine which treatment more effectively improves symptoms such as headache, dizziness, nausea, concentration difficulties, and emotional changes within the first week after injury.
Read full original descriptionShow less
Participants will be enrolled across two Montefiore emergency departments and followed using a validated post-concussion symptom questionnaire. Findings from this study may help improve evidence-based treatment strategies for patients experiencing concussion-related symptoms after head trauma.
The 2 groups in the trial
- Metoclopramide 10 mgExisting treatment, for comparison
Metoclopramide 10 mg IV over 15 minutes
Treatment: Metoclopramide 10mg
- AcetaminophenExisting treatment, for comparison
1000 Mg IV over 15 minutes
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Study of Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment
- Record updated
- 1 October 2026